Genfit SA  

(Public, EPA:GNFT)   Watch this stock  
Find more results for EPA:ALGFT
21.97
-1.54 (-6.55%)
Apr 24 - Close
EPA real-time data - Disclaimer
Currency in EUR
Range 21.53 - 23.75
52 week 4.01 - 36.64
Open 23.75
Vol / Avg. 549,418.00/274,623.00
Mkt cap 368.21M
P/E     -
Div/yield     -
EPS -0.58
Shares 16.76M
Beta     -
Inst. own     -
Mar 28, 2014
GENFIT at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference
Feb 11, 2014
GENFIT at Biotechnology Industry Organization CEO & Investor Conference
  

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin -274.56% -90.04%
Operating margin -192.68% -128.38%
EBITD margin - -115.60%
Return on average assets - -20.55%
Return on average equity - -95.86%
Employees 76 -
CDP Score - -

Address

885 Avenue Eugene Avinee, Parc Eurasante
LOOS, 59120
France
+33-3-20164000 (Phone)
+33-3-20164001 (Fax)

Website links

Description

Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. It develops diagnostic solution for cardiometabolic and neurodegenerative diseases. It focuses on a number of disorders, including diabetes, vascular inflammation, atherosclerosis and others. The Company works in collaboration with such pharmaceutical companies as Sanofi-Aventis, Solvay Group, Kowa Pharmaceutical, UCB Pharma, Pierre Fabre, Pfizer and Servier Laboratories. It operates wholly owned subsidiaries, such as Genfit Corporation, located in Cambridge, the United States and Genfit Pharmaceuticals SAS. As of December 31, 2010, Holding Biotech Avenir held a 24.15% stake in the Company´┐Żs shareholdings.

Officers and directors

Xavier Guille Des Buttes Chairman of the Supervisory Board
Jean - Francois Mouney Chairman of the Management Board, Chief Executive Officer
Charles Woler M.D., Ph.D. Vice Chairman of the Supervisory Board
Raphael Darteil Chief Operating Officer, Executive Vice President, Member of the Management Board
Nathalie Huitorel Executive Vice President of Finance, Member of the Management Board
Bart Staels President of the Scientific Advisory Board, Member of the Management Board
Xavier Blain Member of the Supervisory Board, Representative of CIC Finance
Philippe Moons Member of the Supervisory Board, Representative of Finorpa
Florence Sejourne Member of the Supervisory Board, Representative of Biotech Avenir
Christian Sergheraert Member of the Supervisory Board, Representative of Universite de Lille II